Taken together, our findings suggest that, although loss of CYLD is an uncommon mechanism in DLBCL and MCL, low CYLD expression is associated with inferior overall survival in DLBCL and MCL patients. This evidence concerns the gene CYLD and mantle cell lymphoma.